81 FR 60711 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 171 (September 2, 2016)

Page Range		60711-60712
FR Document		2016-21120

Federal Register, Volume 81 Issue 171 (Friday, September 2, 2016)

[Federal Register Volume 81, Number 171 (Friday, September 2, 2016)]
[Notices]
[Pages 60711-60712]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-21120]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases Special Emphasis Panel NIAID Clinical Trial Implementation 
Cooperative Agreement (U01).
    Date: September 28, 2016.
    Time: 10:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 5601 Fishers Lane, 
Rockville, MD 20892 (Telephone Conference Call).
    Contact Person: Lynn Rust, Ph.D., Scientific Review Officer, 
Scientific Review

[[Page 60712]]

Program, Division of Extramural Activities, Room 3G42A, National 
Institutes of Health/NIAID, 5601 Fishers Lane, MSC 9823, Bethesda, 
MD 20892-9823, (240) 669-5069, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)


    Dated: August 29, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-21120 Filed 9-1-16; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 81, No. 171 / Friday, September 2, 2016 / Notices 60711

SIM system includes a radial aperture The meeting will be closed to the Name of Committee: National Institute of
block positioned at a plane conjugate to public in accordance with the Allergy and Infectious Diseases Special
the back focal plane of the objective provisions set forth in sections Emphasis Panel; NIAID Clinical Trial
Implementation Cooperative Agreement
lens, thus allowing only high-angle 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., (U01).
marginal annular light beams from a as amended. The grant applications and Date: September 26, 2016.
laser source to excite the sample. The the discussions could disclose Time: 10:00 a.m. to 3:00 p.m.
radial aperture block can be replaced confidential trade secrets or commercial Agenda: To review and evaluate grant
with a digital micromirror device for property such as patentable material, applications.
varying the evanescent wave to allow and personal information concerning Place: National Institutes of Health, 5601
nanometric localization of features in individuals associated with the grant Fishers Lane, Rockville, MD 20892
the axial direction. A spatial light applications, the disclosure of which (Telephone Conference Call).
Contact Person: Lynn Rust, Ph.D.,
modulator (SLM) can be used to alter would constitute a clearly unwarranted Scientific Review Officer, Scientific Review
the phase of the excitation to optimally invasion of personal privacy. Program, Division of Extramural Activities,
induce evanescent, patterned excitation Name of Committee: National Institute of Room 3G42A, National Institutes of Health/
at the sample. Various embodiments of Allergy and Infectious Diseases Special NIAID, 5601 Fishers Lane, MSC 9823,
the TIRF/SIM system allows for high- Emphasis Panel, NIAID Clinical Trial Bethesda, MD 20892–9823, (240) 669–5069,
speed, super-resolution microscopy at Implementation Cooperative Agreement lrust@niaid.nih.gov.
very high signal-to-noise (SNR) ratios (U01). (Catalogue of Federal Domestic Assistance
for biological applications within ∼200 Date: October 5, 2016. Program Nos. 93.855, Allergy, Immunology,
Time: 9:00 a.m. to 11:00 a.m. and Transplantation Research; 93.856,
nm (e.g., the evanescent wave decay Agenda: To review and evaluate grant
length) distance of a coverslip surface. Microbiology and Infectious Diseases
applications. Research, National Institutes of Health, HHS)
Potential Commercial Applications: Place: National Institutes of Health, 5601
• High speed microscopy. Fishers Lane, Rockville, MD 20892, Dated: August 29, 2016.
Competitive Advantages: • Low cost (Telephone Conference Call). Natasha M. Copeland,
of manufacture. Contact Person: Lynn Rust, Ph.D.,
Program Analyst, Office of Federal Advisory
Development Stage: • Prototype. Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities, Committee Policy.
Inventors: Hari Shroff (NIBIB), Justin
Taraska (NHBLI), John Giannini (NIBIB), Room 3G42A, National Institutes of Health/ [FR Doc. 2016–21119 Filed 9–1–16; 8:45 am]
NIAID, 5601 Fishers Lane, MSC 9823, BILLING CODE 4140–01–P
Yicong Wu (NIBIB), Abhishek Kumar
Bethesda, MD 20892–9823, (240) 669–5069,
(NIBIB), Min Guo (NIBIB). lrust@niaid.nih.gov.
Publications (Catalogue of Federal Domestic Assistance DEPARTMENT OF HEALTH AND
Program Nos. 93.855, Allergy, Immunology, HUMAN SERVICES
1. Christensen RP, et al. Untwisting the and Transplantation Research; 93.856,
Caenorhabditis elegans embryo. Microbiology and Infectious Diseases National Institutes of Health
Elife. 2015 Dec 3;4. [PMID: Research, National Institutes of Health, HHS)
26633880] Dated: August 29, 2016. National Institute of Allergy and
2. Curd A., et al. Construction of an Infectious Diseases; Notice of Closed
Natasha M. Copeland,
instant structured illumination Meeting
microscope. Methods. 2015 Oct Program Analyst, Office of Federal Advisory
Committee Policy. Pursuant to section 10(d) of the
15;88:37–47. [PMID: 26210400]
[FR Doc. 2016–21117 Filed 9–1–16; 8:45 am] Federal Advisory Committee Act, as
Intellectual Property: HHS Reference
No. E–006–2016/0. BILLING CODE 4140–01–P amended (5 U.S.C. App.), notice is
• US Provisional Patent Application hereby given of the following meeting.
No. 62/378,307 filed 23 Aug 2016. The meeting will be closed to the
DEPARTMENT OF HEALTH AND public in accordance with the
Licensing Contact: Michael
HUMAN SERVICES provisions set forth in sections
Shmilovich, Esq, CLP; 301–435–5019;
shmilovm@mail.nih.gov. 552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
National Institutes of Health as amended. The grant applications and
Dated: August 29, 2016. the discussions could disclose
Michael Shmilovich, National Institute of Allergy and
Infectious Diseases; Notice of Closed confidential trade secrets or commercial
National Heart, Lung and Blood Institute, property such as patentable material,
Office of Technology Transfer and Meeting
and personal information concerning
Development, National Institutes of Health. Pursuant to section 10(d) of the individuals associated with the grant
[FR Doc. 2016–21114 Filed 9–1–16; 8:45 am] Federal Advisory Committee Act, as applications, the disclosure of which
BILLING CODE 4140–01–P amended (5 U.S.C. App.), notice is would constitute a clearly unwarranted
hereby given of the following meeting. invasion of personal privacy.
The meeting will be closed to the Name of Committee: National Institute of
DEPARTMENT OF HEALTH AND public in accordance with the Allergy and Infectious Diseases Special
HUMAN SERVICES provisions set forth in sections Emphasis Panel NIAID Clinical Trial
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Implementation Cooperative Agreement
National Institutes of Health as amended. The grant applications and (U01).
the discussions could disclose Date: September 28, 2016.
mstockstill on DSK3G9T082PROD with NOTICES

National Institute of Allergy and Time: 10:00 a.m. to 12:00 p.m.
Infectious Diseases; Notice of Closed confidential trade secrets or commercial
property such as patentable material, Agenda: To review and evaluate grant
Meeting applications.
and personal information concerning Place: National Institutes of Health, 5601
Pursuant to section 10(d) of the individuals associated with the grant Fishers Lane, Rockville, MD 20892
Federal Advisory Committee Act, as applications, the disclosure of which (Telephone Conference Call).
amended (5 U.S.C. App.), notice is would constitute a clearly unwarranted Contact Person: Lynn Rust, Ph.D.,
hereby given of the following meeting. invasion of personal privacy. Scientific Review Officer, Scientific Review

VerDate Sep<11>2014 18:25 Sep 01, 2016 Jkt 238001 PO 00000 Frm 00043 Fmt 4703 Sfmt 4703 E:\FR\FM\02SEN1.SGM 02SEN1

60712 Federal Register / Vol. 81, No. 171 / Friday, September 2, 2016 / Notices

Program, Division of Extramural Activities, Dated: August 29, 2016. DEPARTMENT OF HEALTH AND
Room 3G42A, National Institutes of Health/ Natasha M. Copeland, HUMAN SERVICES
NIAID, 5601 Fishers Lane, MSC 9823,
Program Analyst, Office of Federal Advisory
Bethesda, MD 20892–9823, (240) 669–5069, National Institutes of Health
Committee Policy.
lrust@niaid.nih.gov.
[FR Doc. 2016–21118 Filed 9–1–16; 8:45 am]
(Catalogue of Federal Domestic Assistance National Eye Institute; Notice of
BILLING CODE 4140–01–P
Program Nos. 93.855, Allergy, Immunology, Meeting
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Pursuant to section 10(d) of the
Research, National Institutes of Health, HHS) DEPARTMENT OF HEALTH AND
Federal Advisory Committee Act, as
HUMAN SERVICES
amended (5 U.S.C. App.), notice is
Dated: August 29, 2016.
National Institutes of Health hereby given of a meeting of the
Natasha M. Copeland, National Advisory Eye Council.
Program Analyst, Office of Federal Advisory National Institute on Drug Abuse;
Committee Policy. The meeting will be open to the
Notice of Closed Meeting public as indicated below, with
[FR Doc. 2016–21120 Filed 9–1–16; 8:45 am]
attendance limited to space available.
BILLING CODE 4140–01–P Pursuant to section 10(d) of the Individuals who plan to attend and
Federal Advisory Committee Act, as need special assistance, such as sign
amended (5 U.S.C. App), notice is language interpretation or other
DEPARTMENT OF HEALTH AND hereby given of the following meeting.
HUMAN SERVICES reasonable accommodations, should
The meeting will be closed to the notify the Contact Person listed below
National Institutes of Health public in accordance with the in advance of the meeting.
provisions set forth in sections The meeting will be closed to the
National Institute of Allergy and 552b(c)(4) and 552b(c)(6), title 5 U.S.C., public in accordance with the
Infectious Diseases Notice of Closed as amended. The grant applications and provisions set forth in sections
Meeting the discussions could disclose 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
confidential trade secrets or commercial as amended. The grant applications and
Pursuant to section 10(d) of the property such as patentable material,
Federal Advisory Committee Act, as the discussions could disclose
and personal information concerning confidential trade secrets or commercial
amended (5 U.S.C. App.), notice is
individuals associated with the grant property such as patentable material,
hereby given of the following meeting.
applications, the disclosure of which and personal information concerning
The meeting will be closed to the would constitute a clearly unwarranted individuals associated with the grant
public in accordance with the invasion of personal privacy.
provisions set forth in sections applications, the disclosure of which
552b(c)(4) and 552b(c)(6), title 5 U.S.C., Name of Committee: National Institute on would constitute a clearly unwarranted
as amended. The grant applications and Drug Abuse Special Emphasis Panel; invasion of personal privacy.
the discussions could disclose Identification of Genetic and Genomic
Name of Committee: National Advisory
Variants by Next-Gen Sequencing in Non-
confidential trade secrets or commercial Eye Council.
Human Animal Models (U01).
property such as patentable material, Date: October 20, 2016.
Date: September 23, 2016.
and personal information concerning Open: 8:30 a.m. to 1:00 p.m.
Time: 12:00 p.m. to 4:00 p.m.
individuals associated with the grant Agenda: Following opening remarks by the
Agenda: To review and evaluate grant
applications, the disclosure of which Director, NEI, there will be presentations by
applications.
would constitute a clearly unwarranted the staff of the Institute and discussions
Place: National Institutes of Health,
invasion of personal privacy. concerning Institute programs.
Neuroscience Center, 6001 Executive
Place: National Institutes of Health,
Name of Committee: National Institute of Boulevard, Rockville, MD 20852 (Telephone
Terrace Level Conference Rooms, 5635
Allergy and Infectious Diseases Special Conference Call).
Fishers Lane, Bethesda, MD 20892.
Emphasis Panel; NIAID Clinical Trial Contact Person: Jagadeesh S. Rao, Ph.D.,
Implementation Cooperative Agreement Closed: 1:00 p.m. to 5:00 p.m.
Scientific Review Officer, Office of
(U01). Agenda: To review and evaluate grant
Extramural Policy and Review, Division of
Date: October 27, 2016. applications.
Extramural Research, National Institute on
Time: 8:30 a.m. to 10:30 a.m. Place: National Institutes of Health,
Drug Abuse, National Institutes of Health,
Agenda: To review and evaluate grant Terrace Level Conference Rooms, 5635
DHHS, 6001 Executive Boulevard, Room
applications. Fishers Lane, Bethesda, MD 20892.
4234, MSC 9550, Bethesda, MD 02892, 301–
Place: National Institutes of Health, 5601 Contact Person: Paul A. Sheehy, Ph.D.,
443–9511, jrao@nida.nih.gov.
Fishers Lane, Rockville, MD 20892 Director, Division of Extramural Affairs,
(Telephone Conference Call). (Catalogue of Federal Domestic Assistance National Eye Institute, National Institutes of
Contact Person: Lynn Rust, Ph.D., Program Nos.: 93.279, Drug Abuse and Health, 5635 Fishers Lane, Suite 12300,
Scientific Review Officer Scientific Review Addiction Research Programs, National Bethesda, MD 20892, 301–451–2020, ps32h@
Program, Division of Extramural Activities, Institutes of Health, HHS) nih.gov.
Room 3G42A National Institutes of Health/ Dated: August 29, 2016. Information is also available on the
mstockstill on DSK3G9T082PROD with NOTICES

NIAID, 5601 Fishers Lane, MSC 9823, Natasha M. Copeland, Institute’s/Center’s home page:
Bethesda, MD 20892–9823, (240) 669–5069, www.nei.nih.gov, where an agenda and any
lrust@niaid.nih.gov. Program Analyst, Office of Federal Advisory
Committee Policy. additional information for the meeting will
(Catalogue of Federal Domestic Assistance be posted when available.
[FR Doc. 2016–21121 Filed 9–1–16; 8:45 am]
Program Nos. 93.855, Allergy, Immunology, (Catalogue of Federal Domestic Assistance
and Transplantation Research; 93.856, BILLING CODE 4140–01–P
Program Nos. 93.867, Vision Research,
Microbiology and Infectious Diseases National Institutes of Health, HHS)
Research, National Institutes of Health, HHS)

VerDate Sep<11>2014 18:25 Sep 01, 2016 Jkt 238001 PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 E:\FR\FM\02SEN1.SGM 02SEN1

Document Created: 2018-02-09 11:55:37
Document Modified: 2018-02-09 11:55:37

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		September 28, 2016.
FR Citation		81 FR 60711

81 FR 60711 - National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 171 (September 2, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health